Lidocaína B. Braun

Lidocaine, the active ingredient in Lidocaína B. Braun, is a local anesthetic presented as a sterile solution for epidural, infiltration and intradermal use. It provides reversible nerve block to facilitate minor surgical procedures, obstetric analgesia and diagnostic skin testing in adult patients.

GNH USA supplies Lidocaína B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global healthcare institutions. Its portfolio includes a range of injectable medicines for perioperative care.

Lidocaína B. Braun is used to provide local anesthesia in several clinical settings. - Minor surgical procedures: provides surface or deep anesthesia to facilitate incision and suturing. - Epidural analgesia: delivers analgesia for labor, postoperative pain or chronic back pain. - Infiltration anesthesia: numbs tissue surrounding a surgical site for dental, orthopedic or dermatologic interventions. - Intradermal anesthesia: enables painless skin testing and minor dermatologic procedures.

Lidocaine may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Tingling or numbness at the injection site. - Metallic taste or mild mouth irritation. - Dizziness or light‑headed feeling. - Nausea or mild vomiting. Serious or Rare Side Effects: - Seizures or convulsions, especially with high plasma levels. - Cardiac arrhythmias, including ventricular tachycardia. - Severe hypotension or cardiovascular collapse. - Allergic reactions such as rash, urticaria or anaphylaxis.

When using Lidocaína B. Braun, clinicians should observe several safety measures to minimize risk. - Assess patient allergy: verify no known hypersensitivity to amide‑type local anesthetics. - Use lowest effective concentration: select the minimal dose required for the intended procedure. - Monitor cardiovascular status: observe heart rate and blood pressure during and after administration. - Avoid intravascular injection: aspirate before injecting to prevent systemic toxicity. - Adjust dose in hepatic impairment: reduce total dose in patients with liver dysfunction. - Store at room temperature: keep in original container, protect from moisture and light.

Lidocaine can interact with other medicines, altering its efficacy or increasing toxicity. Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may raise lidocaine plasma concentrations and risk toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can significantly increase systemic exposure. Moderate Interactions (Monitor Closely): - Other amide local anesthetics: cumulative effect may enhance neuro‑ or cardiotoxicity. - CYP1A2 inducers (e.g., carbamazepine, rifampin): may reduce lidocaine effectiveness. - Diuretics such as furosemide: can increase free lidocaine levels by altering protein binding. - General anesthetics (e.g., propofol, inhalational agents): additive central nervous system depression.